Rev1 overexpression accelerates N ‐methyl‐ N ‐nitrosourea (MNU)‐induced thymic lymphoma by increasing mutagenesis
Cancer Science · 2024
DOI: 10.1111/cas.16159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Megumi Sasatani und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: DNA-Directed DNA Polymerase, Methylnitrosourea, Mutagenesis, Nucleotidyltransferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Network-Type Joint Usage/Research Center for Radiation Disaster Medical Science at Hiroshima University, Nagasaki University, and Fukushima Medical University, National Institute for Fusion Science Collaborative Research Program, Initiative for Realizing Diversity in the Research Environment (Specific Correspondence Type), a support project for the Development of Human Resources in Scie….
Abstract (Originalsprache)
Rev1 has two important functions in the translesion synthesis pathway, including dCMP transferase activity, and acts as a scaffolding protein for other polymerases involved in translesion synthesis. However, the role of Rev1 in mutagenesis and tumorigenesis in vivo remains unclear. We previously generated Rev1 ‐overexpressing ( Rev1 ‐Tg) mice and reported that they exhibited a significantly increased incidence of intestinal adenoma and thymic lymphoma (TL) after N ‐methyl‐ N ‐nitrosourea (MNU) treatment. In this study, we investigated mutagenesis of MNU‐induced TL tumorigenesis in wild‐type (WT) and Rev1 ‐Tg mice using diverse approaches, including whole‐exome sequencing (WES). In Rev1 ‐Tg TLs, the mutation frequency was higher than that in WT TL in most cases. However, no difference in the number of nonsynonymous mutations in the Catalogue of Somatic Mutations in Cancer (COSMIC) genes was observed, and mutations involved in Notch1 and MAPK signaling were similarly detected in both TLs. Mutational signature analysis of WT and Rev1 ‐Tg TLs revealed cosine similarity with COSMIC mutational SBS5 (aging‐related) and SBS11 (alkylation‐related). Interestingly, the total number of mutations, but not the genotypes of WT and Rev1 ‐Tg, was positively correlated with the relative contribution of SBS5 in individual TLs, suggesting that genetic instability could be accelerated in Rev1 ‐Tg TLs. Finally, we demonstrated that preleukemic cells could be detected earlier in Rev1 ‐Tg mice than in WT mice, following MNU treatment. In conclusion, Rev1 overexpression accelerates mutagenesis and increases the incidence of MNU‐induced TL by shortening the latency period, which may be associated with more frequent DNA damage‐induced genetic instability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
- Department of Biochemistry and Molecular Biology and Zhejiang Key Laboratory of Pathophysiology, School of Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo, China.
- Department of Radiation Effects Research, Institute for Radiological Sciences, National Institutes for Quantum Science and Technology, Chiba, Japan.
- Department of Genome Dynamics, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.
- Department of Molecular Pharmaco-Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Biosample Research Center, Radiation Effects Research Foundation, Hiroshima, Japan.
ORCID-Profile: Megumi Sasatani, Hiroaki Honda, Shizuko Kakinuma
Förderung
- Network-Type Joint Usage/Research Center for Radiation Disaster Medical Science at Hiroshima University, Nagasaki University, and Fukushima Medical University
- National Institute for Fusion Science Collaborative Research Program
- Initiative for Realizing Diversity in the Research Environment (Specific Correspondence Type), a support project for the Development of Human Resources in Scie…
- Japan Society for the Promotion of Science, JSPS KAKENHI
- Nuclear Energy S&T and Human Resource Development Project
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science
Zitieren
APA
Sasatani, M., Xi, Y., Daino, K., Ishikawa, A., Masuda, Y., Kajimura, J., Piao, J., Zaharieva, E. K., Honda, H., Zhou, G., Hamasaki, K., Kusunoki, Y., Shimura, T., Kakinuma, S., Shimada, Y., Doi, K., Ishikawa-Fujiwara, T., Sotomaru, Y., & Kamiya, K. (2024). Rev1 overexpression accelerates N ‐methyl‐ N ‐nitrosourea (MNU)‐induced thymic lymphoma by increasing mutagenesis. Cancer Science. https://doi.org/10.1111/cas.16159
Vancouver
Sasatani M, Xi Y, Daino K, Ishikawa A, Masuda Y, Kajimura J, et al. Rev1 overexpression accelerates N ‐methyl‐ N ‐nitrosourea (MNU)‐induced thymic lymphoma by increasing mutagenesis. Cancer Science. 2024. doi:10.1111/cas.16159
BibTeX
@article{Sasatani2024,
author = {Sasatani, Megumi and Xi, Yang and Daino, Kazuhiro and Ishikawa, Atsuko and Masuda, Yuji and Kajimura, Junko and Piao, Jinlian and Zaharieva, Elena Karamfilova and Honda, Hiroaki and Zhou, Guanyu and Hamasaki, Kanya and Kusunoki, Yoichiro and Shimura, Tsutomu and Kakinuma, Shizuko and Shimada, Yoshiya and Doi, Kazutaka and Ishikawa-Fujiwara, Tomoko and Sotomaru, Yusuke and Kamiya, Kenji},
title = {Rev1 overexpression accelerates N ‐methyl‐ N ‐nitrosourea (MNU)‐induced thymic lymphoma by increasing mutagenesis},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16159}
}
EUVIMED